The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.
Click on the button below to create your account and get immediate access to thousands of articles.
Jiuzhitang (000989.SZ): new drug approved by U.S. FDA for clinical trials
Jiuzhitang Co., Ltd. (000989.SZ), a leading Chinese company engaged in the traditional Chinese medicine (TCM), announced on Sunday evening that a new drug developed by its wholly subsidiary has been approved by the U.S. Food and Drug Administration (FDA).
July19,2021
Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.
Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.